Australia markets close in 1 hour

    +46.30 (+0.61%)
  • ASX 200

    +38.90 (+0.54%)

    +0.0013 (+0.18%)
  • OIL

    +0.61 (+0.88%)
  • GOLD

    -1.40 (-0.08%)

    +2,395.40 (+3.42%)
  • CMC Crypto 200

    +60.55 (+4.80%)

    +0.0014 (+0.23%)

    +0.0023 (+0.22%)
  • NZX 50

    +1.56 (+0.01%)

    +134.12 (+0.85%)
  • FTSE

    +109.96 (+1.54%)
  • Dow Jones

    +646.95 (+1.87%)
  • DAX

    +210.81 (+1.39%)
  • Hang Seng

    +350.58 (+1.50%)
  • NIKKEI 225

    +480.11 (+1.72%)

Exosomes Market Size Report 2021-2028 | Share, Growth Factors, Trends, Restraining Factors, Competitive Landscape, Revenue, Forecast Analysis

·4-min read

Key Companies Covered in the Exosomes Market Research Report are ExoDx, Hitachi Chemicals, QIAGEN, Aethlon Medical, NanoSomiX, Thermo Fisher Scientific, Malvern Panalytical, System Biosciences, Sistemic Scotland Limited and others.

Pune, India, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The global exosomes market size is expected to gain momentum owing to the rising prevalence of cancer during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, “Exosomes Market, 2021-2028.” The rising prevalence of cancer, technical improvements in separation and analytical processes, and expanding sophisticated uses are some of the reasons driving market expansion. The increasing frequency of cancer patients has a direct influence on the market. According to the GLOBOCAN 2020 study, 19.29 million individuals were living with cancer in 2010, and this figure is anticipated to grow over the next two decades. According to the National Cancer Institute's 2018 report, an estimated 1.7 million new instances of cancer were identified in the country, and almost 0.6 million individuals died as a result of cancer.

Request a Sample Copy of the Research Report:

Industry Development-

  • March 2020: Extracorporeal elimination ofmicrovesicularparticles is a European patent number. Aethlon Medical has announced. This patent covers hem purifier technology, which is used to remove immune suppressive and potentially cancer-promoting exosomes from the circulatory system.

COVID-19 Impact-

Government Restrictions to Hamper the Market

Pharmaceutical and biotech firms, together with governments throughout the world, are collaborating to handle the COVID-19 epidemic, from vaccine research to planning for medication supply chain difficulties. Furthermore, frequently used medicines have shown a substantial increase in demand for the treatment of COVID-19. Due to the increased demand for these medications, makers of COVID-19 management pharmaceuticals have a big potential since many industrialized nations are running out of these drugs. The pharmaceutical and biotechnology industries are projected to develop significantly in the future because of the need for COVID-19 vaccines and treatment medicines.

To get to know more about the short-term and long-term impact of COVID19 on this market, please visit:


By application, the market is segmented into therapeutics and diagnostics. On the basis of product, the market is segregated into instruments, reagents, software. On the basis of end-user, the market is categorized into hospitals, cancer institutes, and others. Finally, by geography, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

What does the Report Offer?

This report provides an analytical portrayal of the exosomes business, current trends, and future projections to identify potential investment opportunities. The research includes data on major drivers, constraints, and opportunities and a thorough market share analysis.

Get your Customized Research Report:

Drivers & Restraints-

Increasing Demand in Therapeutic Application to Stimulate Growth

The global exosomes market growth is expected to grow due to the rising growth of therapeutic applications during the projected period. According to clinical research, the therapeutic is expected to be one of the most prominent therapeutics of immune disorder, inflammation, Lyme, and persistent degenerative diseases. It helps to regulate processes within the organ during treatment. This aspect has enhanced the research activity in exosome therapy development all over the world. As a result, clinicians and researchers are shifting their focus to exosome therapeutics. Exosome therapeutics are widely utilized in the treatment of autoimmune illness, chronic inflammation, Lyme disease, and chronic degenerative diseases in the contemporary environment.


Increasing Healthcare Infrastructure to Promote Growth in North America

North America is expected to hold the largest global exosomes market share during the forecast period. Because of improved healthcare infrastructure, effective government policies, a big base of multinational firms, and high public knowledge about diagnostics and healthcare, the North American area maintains one of the highest shares of the industry.

Europe is expected to have a sizable share of the market. This is due to the increasing prevalence of cancer, and significant per capita healthcare expenditure by the government is driving the growth of the region.

Competitive Landscape-

Increasing Number of Mergers to Spur Demand Opportunities

The report discusses major advancements in the exosomes industry, as well as organic and inorganic growth methods. Various businesses are concentrating on organic growth methods such as new launches, product approvals, and other things like patents and events. These efforts have opened the path for market participants to expand their business and consumer base. With the growing demand for health coaches in the global industry, market players in the market are expected to benefit from attractive growth possibilities in the future.

List of Key Players Profiled in the Global Market for Exosomes:

  • ExoDx

  • Hitachi Chemicals


  • Aethlon Medical

  • NanoSomiX

  • Thermo Fisher Scientific

  • Malvern Panalytical

  • System Biosciences

  • Sistemic Scotland Limited

Enquire before buying:

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting